LINC00330

Across TCGA pan-cancer cohorts, LINC00330 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC00330 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC00330 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00330 expression acts as an unfavorable survival marker, although some lineages such as CESC and PRAD show a favorable association.

KIRC, SKCM, and MESO are the cancer types where LINC00330 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Quartile	All	0.455	0.704	.001	83	view →
SKCM	DFS	Quartile	All	0.626	0.769	<.001	74	view →
MESO	OS	Tertile	All	0.052	0.528	.016	54	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
SARC	OS	Tertile	All	0.318	0.602	<.001	36	view →
LIHC	DFS	Tertile	II,III,IV	0.194	0.496	.004	36	view →
CESC	OS	Median	All	0.933	0.818	.002	28	view →
COAD	OS	Tertile	III,IV	0.634	0.873	.004	21	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
LGG	DFS	Quartile	All	0.182	0.483	<.001	18	view →
THYM	DFS	Tertile	II,III,IV	0.480	0.799	.007	13	view →
PRAD	DFS	Tertile	All	0.928	0.861	.019	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC00330–KIRC (DFS)

Open the KIRC breakdown →